Cardiovascular disease and chronic kidney disease: insights and an update

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Chronic kidney disease (CKD) is highly prevalent, causing significant morbidity and mortality, particularly from cardiovascular disease (CVD).
• Current treatment guidelines for CVD in CKD patients are based on limited evidence, often extrapolating from studies in patients with normal renal function.
• Inconsistent definitions of CKD and renal function measurement have historically confounded research data.

Purpose of the Study:

• To review the current understanding of CKD as a significant cardiovascular risk factor.
• To outline existing treatment options for cardiovascular disease in patients with CKD.
• To identify future research directions for optimizing CVD management in this high-risk population.

Main Methods:

• This is a review article, synthesizing existing literature and clinical practice guidelines.
• It critically evaluates the evidence base for managing cardiovascular disease in chronic kidney disease.
• The review discusses the exclusion of CKD patients from major therapeutic trials.

Main Results:

• CKD patients face a higher risk of cardiovascular complications than even diabetic patients.
• There is a systematic exclusion of CKD patients from cardiovascular therapeutic trials, limiting evidence-based treatment strategies.
• The lack of consistent definitions for CKD and renal function has hampered research.

Conclusions:

• CKD is a critical, yet understudied, independent risk factor for cardiovascular disease.
• There is an urgent need for dedicated clinical trials and consistent definitions to improve cardiovascular care for CKD patients.
• Further research is essential to develop effective, evidence-based treatments for cardiovascular complications in individuals with chronic kidney disease.